FTC Extends Scrutiny Of MDS' $650M Sale To Danaher
Antitrust officials scrutinizing Danaher Corp.'s proposed acquisition of MDS Inc.'s analytical technologies unit have extended their review of the $650 million cash transaction....To view the full article, register now.
Already a subscriber? Click here to view full article